catechin has been researched along with etoposide in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Ichijo, H; Inazawa, Y; Isemura, M; Kobayashi, N; Nishitoh, H; Saeki, K; Yuo, A; Zhang, H | 1 |
| Bode, AM; Choi, BY; Choi, HS; Dong, Z; Ermakova, SP; Kang, BS; Ma, WY; Schuster, TF | 1 |
| Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
| Aller, P; Calle, C; de Blas, E; Sánchez, Y | 1 |
| Baran, J; Bukowska-Straková, K; Krzysciak, W; Papiez, MA | 1 |
| Papież, MA | 1 |
| Li, H; Sun, X; Xie, P; Xing, L; Yu, J; Zhang, X; Zhao, H; Zhu, W | 1 |
1 trial(s) available for catechin and etoposide
| Article | Year |
|---|---|
A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Catechin; Chemoradiotherapy; Cisplatin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage | 2014 |
9 other study(ies) available for catechin and etoposide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and recep
Topics: Antioxidants; Apoptosis; Blotting, Western; Caspase 8; Caspase 9; Caspases; Catechin; Cell Death; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Etoposide; Flavonoids; Flow Cytometry; Glutathione; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Models, Biological; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Oxidation-Reduction; Oxygen; p38 Mitogen-Activated Protein Kinases; Phenols; Polymers; Reactive Oxygen Species; Signal Transduction; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; U937 Cells; Urokinase-Type Plasminogen Activator | 2002 |
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 7; Caspase Inhibitors; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Etoposide; Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Protein Conformation; Urinary Bladder Neoplasms | 2006 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
Topics: Adamantane; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Catechin; Cell Cycle; Drug Synergism; Enzyme Activation; Estradiol; Etoposide; Genistein; HL-60 Cells; Humans; Hydroquinones; Immunoblotting; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Oxides; Protein Kinase Inhibitors; Reactive Oxygen Species; RNA, Small Interfering; U937 Cells | 2009 |
(-)-Epicatechin enhances etoposide-induced antileukaemic effect in rats with acute myeloid leukaemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow Cells; Catechin; Drug Synergism; Etoposide; Fluorescence Recovery After Photobleaching; Leukemia, Promyelocytic, Acute; Lipid Peroxidation; Male; Malondialdehyde; Organ Size; Rats; Rats, Inbred BN; Spleen; Superoxide Dismutase | 2012 |
The influence of curcumin and (-)-epicatechin on the genotoxicity and myelosuppression induced by etoposide in bone marrow cells of male rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Marrow Cells; Catechin; Curcumin; DNA Damage; Etoposide; Male; Oxidative Stress; Polyphenols; Rats; Rats, Inbred BN | 2013 |